Terms: = Kidney tumors AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
33 results:
1. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
[TBL] [Abstract] [Full Text] [Related]
2. Low risk of embryonic and other cancers in pik3ca-related overgrowth spectrum: Impact on screening recommendations.
Faivre L; Crépin JC; Réda M; Nambot S; Carmignac V; Abadie C; Mirault T; Faure-Conter C; Mazereeuw-Hautier J; Maza A; Puzenat E; Collonge-Rame MA; Bursztejn AC; Philippe C; Thauvin-Robinet C; Chevarin M; Abasq-Thomas C; Amiel J; Arpin S; Barbarot S; Baujat G; Bessis D; Bourrat E; Boute O; Chassaing N; Coubes C; Demeer B; Edery P; El Chehadeh S; Goldenberg A; Hadj-Rabia S; Haye D; Isidor B; Jacquemont ML; Van Kien PK; Lacombe D; Lehalle D; Lambert L; Martin L; Maruani A; Morice-Picard F; Petit F; Phan A; Pinson L; Rossi M; Touraine R; Vanlerberghe C; Vincent M; Vincent-Delorme C; Whalen S; Willems M; Marle N; Verkarre V; Devalland C; Devouassoux-Shisheboran M; Abad M; Rioux-Leclercq N; Bonniaud B; Duffourd Y; Martel J; Binquet C; Kuentz P; Vabres P
Clin Genet; 2023 Nov; 104(5):554-563. PubMed ID: 37580112
[TBL] [Abstract] [Full Text] [Related]
3. Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis.
Feng J; Xu B; Dai C; Wang Y; Xie G; Yang W; Zhang B; Li X; Wang J
Oncol Res; 2021; 29(5):331-349. PubMed ID: 37305161
[TBL] [Abstract] [Full Text] [Related]
4. High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
Lang M; Schmidt LS; Wilson KM; Ricketts CJ; Sourbier C; Vocke CD; Wei D; Crooks DR; Yang Y; Gibbs BK; Zhang X; Klumpp-Thomas C; Chen L; Guha R; Ferrer M; McKnight C; Itkin Z; Wangsa D; Wangsa D; James A; Difilippantonio S; Karim B; Morís F; Ried T; Merino MJ; Srinivasan R; Thomas CJ; Linehan WM
J Exp Clin Cancer Res; 2023 Apr; 42(1):99. PubMed ID: 37095531
[TBL] [Abstract] [Full Text] [Related]
5. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
6. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
[TBL] [Abstract] [Full Text] [Related]
7. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
8. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.
Li M; Liu G; Jin X; Guo H; Setrerrahmane S; Xu X; Li T; Lin Y; Xu H
Mol Cancer; 2022 Sep; 21(1):181. PubMed ID: 36117171
[TBL] [Abstract] [Full Text] [Related]
9. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
10. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
[TBL] [Abstract] [Full Text] [Related]
12. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression.
Anderson WJ; Tsai HK; Sholl LM; Hirsch MS
Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731
[No Abstract] [Full Text] [Related]
13. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract] [Full Text] [Related]
14. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract] [Full Text] [Related]
15. The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
16. Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression.
Song Y; Wang M; Tong H; Tan Y; Hu X; Wang K; Wan X
Oncogene; 2021 Jan; 40(3):633-646. PubMed ID: 33208911
[TBL] [Abstract] [Full Text] [Related]
17. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract] [Full Text] [Related]
18. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
Alessandrino F; Williams K; Nassar AH; Gujrathi R; Silverman SG; Sonpavde G; Shinagare AB
Radiology; 2020 Jun; 295(3):572-580. PubMed ID: 32228295
[TBL] [Abstract] [Full Text] [Related]
19. Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma.
Song J; Song F; Liu K; Zhang W; Luo R; Tang Y; Ran L
Aging (Albany NY); 2019 Nov; 11(22):10316-10337. PubMed ID: 31743108
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the pi3k/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract] [Full Text] [Related]
[Next]
